Key Takeaways
- Dermatology software is expanding rapidly, with the global market estimated at $362.63 million in 2025 and projected to grow at a 10.6% CAGR through 2032.
- AI, teledermatology and cloud technology are major 2026 trends, with 35% of dermatology platforms featuring AI-enhanced image analysis and more than 60% of software being cloud-based.
- Rising skin disease prevalence, dermatologist shortages and patient access challenges are accelerating demand for dermatology EMR, telehealth, automation and practice management software worldwide.
Dermatology software transforms how skin care practices manage patients, clinical records, billing, telehealth and diagnostics in 2026. The market is expanding as dermatologists adopt cloud platforms, specialized EMRs and AI-assisted tools to improve efficiency, address growing patient demand and deliver more accessible dermatological care worldwide.
The dermatology software industry is entering a period of rapid digital transformation in 2026, driven by growing electronic health record adoption, teledermatology, artificial intelligence, cloud-based platforms, revenue cycle management, and rising demand for more efficient patient care. The global dermatology software market was valued at $327.88 million in 2024 and reached an estimated $362.63 million in 2025, with projections indicating a 10.6% compound annual growth rate through 2032.
Also, read our article on the Top 10 Best Dermatology Software.
Specialized dermatology EMR software represents an especially important part of this expansion. The global dermatology EMR software market was valued at $512.3 million in 2024 and is projected to reach $1.389 billion by 2033, growing at an estimated 11.6% CAGR. In the United States, dermatology EHR adoption has already reached approximately 80%, suggesting that the market is increasingly shifting from basic digitization toward platform upgrades, interoperability, automation, AI-assisted workflows, and specialty-specific functionality.
Teledermatology is expanding even faster. One estimate valued the global teledermatology market at $14.99 billion in 2024 and forecasts it to reach $41.08 billion by 2030, representing a 17.9% CAGR. Store-and-forward teledermatology accounted for 46.3% of the market in 2024, while North America represented 38.7% of global revenue. These figures demonstrate how remote consultations and asynchronous image review are becoming increasingly important components of modern dermatology care.
Artificial intelligence is another major dermatology software trend to watch in 2026. Around 35% of dermatology software platforms already feature AI-enhanced image analysis tools, while a 2025 meta-analysis cited in the research reported pooled AI sensitivity of 91% for skin-lesion diagnosis. At the same time, more than 60% of dermatology software was estimated to be cloud-based in 2025, highlighting the industry’s broader transition toward connected, scalable, and AI-enabled software ecosystems.
The underlying demand for these technologies is substantial. Skin diseases affect an estimated 900 million people worldwide, approximately 125 million people live with psoriasis, and 50 million Americans experience acne. Access constraints add further pressure: the average wait for a U.S. dermatology appointment was reported at 34.5 days, while 46% of dermatologists reported burnout. These challenges strengthen the business and clinical case for software that can automate workflows, improve scheduling, support remote care, streamline billing, and increase practitioner capacity.
This collection of the Top 103 Dermatology Software Statistics, Data & Trends in 2026 examines the numbers shaping the industry’s future, from dermatology software and EMR market growth to teledermatology, AI diagnostics, cloud adoption, revenue cycle management, workforce shortages, skin disease prevalence, regional opportunities, and healthcare investment. For dermatology practices, software vendors, healthcare technology companies, investors, researchers, and industry decision-makers, these statistics provide a data-driven view of where the dermatology software market stands in 2026 and where it may be heading next.
Before we venture further into this article, we would like to share who we are and what we do.
About 9cv9
9cv9 is a business tech startup based in Singapore and Asia, with a strong presence all over the world.
With over ten years of startup and business experience, and being highly involved in connecting with thousands of companies and startups, the 9cv9 team has listed some important and crucial software tools in this review.
If you like to get your company listed in our top B2B software reviews, check out our world-class 9cv9 Media and PR service and pricing plans here.
Top 103 Dermatology Software Statistics, Data & Trends in 2026
🏦 MARKET SIZE & OVERALL GROWTH
1. USD $284.37 million — The global dermatology software market was valued at $284.37 million in 2023.
The dermatology software market crossed the $284 million mark in 2023, underlining the accelerating shift toward digital practice management in skin-care specialties worldwide.
2. USD $327.88 million — The dermatology software market reached $327.88 million in 2024.
Year-on-year growth of roughly 15% between 2023 and 2024 signals robust investor and practitioner confidence in dedicated dermatology technology platforms.
3. USD $362.63 million — Market valuation in 2025 according to the most recent April 2026 update.
Sustained double-digit growth into 2025 confirms that dermatology software is among the fastest-growing niches in healthcare IT, outpacing the broader EMR market.
4. 10.6% CAGR — Projected compound annual growth rate from 2025 to 2032.
A CAGR of 10.6% places dermatology software well above the broader healthcare IT average, driven by AI integration, EHR mandates, and rising skin disease prevalence.
5. USD $574.57 million — Forecast market size by the end of 2030.
Doubling in market size within seven years reflects the combination of organic practice growth and accelerated software adoption across emerging markets.
6. USD $663.74 million — Market projection by 2031.
Approaching the $700 million mark by 2031, dermatology software is transitioning from a niche product to a mainstream healthcare-IT spend category globally.
7. USD $734.10 million — Expected market value by 2032.
The march toward $734 million by 2032 underscores the multi-year tailwind created by regulatory EHR incentives, aging populations, and teledermatology expansion.
8. USD $217.59 million — Alternative 2024 market estimate (Fundamental Business Insights methodology).
Variations across analyst methodologies — ranging from $217M to $327M for 2024 — reflect differing scope definitions, but all trajectories point firmly upward.
9. USD $404.63 million — Alternative 2034 forecast (6.4% CAGR, Fundamental Business Insights).
Even conservative growth models project the market more than doubling by 2034, representing a significant long-term opportunity for software vendors and investors.
10. USD $228.73 million — Industry revenue estimate for 2025 under the 6.4% CAGR scenario.
Across all research methodologies, 2025 marks the inflection year where dermatology software spending becomes mainstream in non-US markets as well.
💻 DERMATOLOGY EMR SOFTWARE
11. USD $512.3 million — Global dermatology EMR software market size in 2024.
The EMR sub-segment alone exceeded $512 million in 2024, illustrating that electronic record management is the single largest software investment for dermatology practices.
12. 11.6% CAGR — Dermatology EMR software growth rate 2025–2033.
At 11.6%, the EMR sub-market is growing even faster than the overall dermatology software market, driven by specialty-specific workflow demands.
13. USD $1.389 billion — Dermatology EMR software projected value by 2033.
Surpassing $1.3 billion by 2033, the EMR market alone will be nearly four times its 2024 size, presenting massive opportunities for platform consolidation.
14. USD $224.7 million — North America’s share of the dermatology EMR market in 2024.
North America accounts for approximately 44% of global dermatology EMR revenue, a dominance explained by high regulatory incentive spending and advanced healthcare infrastructure.
15. 80% — Dermatology EHR adoption rate in the United States.
With four in five U.S. dermatology practices on EHR platforms, the market has moved past early adopter stage and is now focused on optimizing and upgrading existing systems.
16. 6–7% — Year-on-year EMR software demand growth in 2025.
Steady 6–7% demand growth in 2025 reflects a mature but expanding market where interoperability upgrades and AI add-ons are the primary purchase drivers.
17. 35%+ — Epic Systems’ market share among large multispecialty healthcare organisations.
Epic’s growing dominance in large organisations pulls dermatology practices within multispecialty systems onto unified EHR platforms, consolidating vendor competition.
18. 70% — European healthcare providers planning to invest in digital solutions (European Commission survey).
European digital health investment plans signal an impending surge in dermatology EMR adoption across Germany, UK, and France — the three largest European markets.
19. 6–8 weeks — Typical implementation timeline for a new dermatology EMR system.
An average EMR rollout of six to eight weeks is relatively short, lowering the barrier to adoption for small and mid-sized dermatology groups considering their first digital transition.
20. 97% — Average MIPS score achieved by Nextech dermatology EHR users.
A 97% MIPS score for Nextech customers translates directly to maximised Medicare reimbursements, making software investment a financially self-justifying decision.
📡 TELEDERMATOLOGY
21. USD $14.99 billion — Global teledermatology market size in 2024 (Grand View Research).
Teledermatology’s $15 billion footprint in 2024 dwarfs the broader dermatology software market, underscoring just how rapidly remote consultation has become central to care delivery.
22. 17.9% CAGR — Teledermatology growth rate from 2025 to 2030.
Growing at nearly 18% annually, teledermatology is one of the fastest-expanding segments in all of digital health, not just dermatology.
23. USD $41.08 billion — Teledermatology forecast by 2030 (Grand View Research).
The near-tripling of the teledermatology market within six years reflects both pandemic-accelerated normalisation of virtual visits and persistent dermatologist shortages.
24. USD $9.03 billion — Alternative 2024 valuation (Market.us, December 2025).
Across different methodologies, 2024 teledermatology revenue ranges from $9B to $15B — all sources agree on explosive directional growth.
25. USD $36.85 billion — Teledermatology market forecast by 2034 at 15.1% CAGR.
The teledermatology sector is on course to be a $37 billion industry by 2034, representing one of the highest-value opportunities in digital specialty care.
26. 15.1% CAGR — Teledermatology growth rate 2025–2034 (Market.us methodology).
At 15%, teledermatology grows three times faster than the broader global EMR market, reinforcing its role as the primary growth engine in dermatology software ecosystems.
27. USD $60.96 billion — Expert Market Research 2035 forecast for teledermatology.
Projections ranging up to $61 billion by 2035 across multiple research houses indicate consensus on the segment’s transformative long-run growth trajectory.
28. 38.7% — North America’s share of the global teledermatology market in 2024.
With nearly 40% of global teledermatology revenue, North America remains the dominant region, underpinned by reimbursement clarity and digital health infrastructure.
29. 85.8% — Services segment share of the teledermatology market in 2023.
The overwhelming dominance of services over products in teledermatology confirms that recurring subscription and consultation revenue drives most platform economics.
30. 46.3% — Store-and-forward segment share in global teledermatology 2024.
The store-and-forward modality — where images are reviewed asynchronously — claims nearly half of teledermatology revenue, reflecting its efficiency and scalability.
31. USD $16.30 billion — Global teledermatology market in 2025 (Expert Market Research).
Breaching $16 billion in 2025 alone signals that teledermatology is no longer a pandemic-era niche but a permanent fixture of dermatological care delivery.
32. USD $5.09 billion — US teledermatology market value in 2024.
The United States is the single largest national teledermatology market, accounting for roughly one-third of global revenues in 2024.
33. USD $19.44 billion — Global teledermatology estimate for 2026 (Straits Research).
Approaching $20 billion by 2026, teledermatology spending is accelerating through mid-decade as platform ecosystems mature and insurance coverage expands.
34. 20.2% CAGR — Teledermatology growth rate through 2034 in one high-range estimate (Precedence Research).
Under the most optimistic scenario, the teledermatology market growing at 20% per year could reach $90 billion by 2034, driven by AI-powered diagnostics.
🤖 AI & TECHNOLOGY INTEGRATION
35. 35% — Share of dermatology software platforms featuring AI-enhanced image analysis tools.
One in three dermatology platforms already embeds AI image analysis, a proportion expected to climb sharply as FDA clearances accumulate and reimbursement frameworks solidify.
36. 98.04% — Accuracy of the LA-CapsNet AI model for skin lesion classification (2024 study).
A 98% accuracy rate for AI-assisted lesion classification approaches the performance ceiling, setting a benchmark that platforms must reach to secure clinical trust.
37. 0.88 AUROC — Pooled diagnostic accuracy of AI across 70,000+ test images (2025 meta-analysis).
An AUROC of 0.88 from a rigorously conducted meta-analysis represents clinically meaningful diagnostic performance, supporting AI as a genuine augmentation tool for dermatologists.
38. 91% — Pooled AI sensitivity for skin-lesion diagnosis (HSROC analysis, Tjiu & Lu, 2025).
Achieving 91% sensitivity, AI-based dermatology tools are approaching the sensitivity of experienced dermatologists on standardised image datasets.
39. 64% — Pooled AI specificity in the same 2025 meta-analysis.
The relatively lower specificity of 64% indicates that AI performs best as a triage and screening tool rather than a standalone diagnostic replacement.
40. 90% — Sensitivity of deep learning models trained on smartphone images vs. general practitioners.
Deep learning on smartphone imagery outperforming GPs at detecting malignant lesions validates consumer-facing dermatology apps as clinically meaningful screening tools.
41. 85% — Specificity of smartphone-based deep learning models for skin cancer detection.
High specificity alongside high sensitivity confirms that mobile AI can reduce unnecessary referrals while still catching the majority of true malignancies.
42. 71% — US hospitals using predictive AI integrated with EHRs in 2024.
With nearly three-quarters of US hospitals deploying EHR-integrated AI, dermatology AI modules are increasingly standard rather than cutting-edge offerings.
43. 60%+ — Share of dermatology software that is cloud-based in 2025.
Cloud-based deployment now represents the majority of dermatology software, enabling multi-site access, automatic updates, and reduced on-premise IT burden.
44. 35% — Pay-per-use model share of the teledermatology market.
A pay-per-use model serving 35% of teledermatology users lowers access barriers for occasional users and smaller practices not ready for subscription commitments.
45. 25% — Insurance-based payment model’s share of teledermatology revenue.
Insurance coverage for teledermatology is expanding as payers recognise its cost-effectiveness, representing a growing pipeline of automatically reimbursable consultations.
🏥 PRACTICE MANAGEMENT & RCM
46. 99% — Net collection rate achieved by a 120+ provider New York dermatology practice after implementing eClinicalWorks RCM.
Achieving a 99% net collection rate demonstrates that purpose-built RCM software can virtually eliminate revenue leakage in even the largest multi-site dermatology groups.
47. 50% — Reduction in claim submission lag after RCM software deployment.
Cutting claim lag by half dramatically accelerates cash flow cycles, reducing the average days in accounts receivable and improving a practice’s working capital position.
48. 33% — Reduction in payer rejections following RCM optimisation.
A one-third drop in payer rejections translates directly into fewer administrative hours spent on appeals, freeing staff to focus on patient-facing activities.
49. 97% — Average MIPS score for Nextech dermatology EHR customers.
Nextech users scoring an average of 97% in the MIPS programme maximise government incentive payments, effectively offsetting a significant portion of software subscription costs.
50. 10% — Revenue and cash-flow increase attributed to specialised dermatology RCM software.
A 10% revenue uplift from RCM software delivers a rapid return on investment, making the business case for adoption straightforward even for cost-conscious practices.
51. $40 billion — Total revenue managed annually across Unlimited Systems’ 3,500+ healthcare client base.
With $40 billion in healthcare revenue flowing through a single RCM vendor’s platform, the scale of dermatology billing operations underscores the criticality of specialised software.
👩⚕️ WORKFORCE SHORTAGE & CARE ACCESS
52. 34.5 days — Average wait time for a US dermatology appointment in 2022 (a 7% increase since 2017).
A 34.5-day average wait — and growing — represents a structural access gap that teledermatology and AI-assisted triage software are uniquely positioned to close.
53. Up to 86,000 — Projected US physician shortage by 2036 (AAMC, March 2024).
A looming shortage of 86,000 physicians, including specialists, creates an urgent market pull for software solutions that expand dermatologist capacity without adding headcount.
54. 46% — Dermatologists reporting burnout in the Medscape 2024 Physician Burnout & Depression Report.
Nearly half of dermatologists experiencing burnout highlights a critical opportunity for workflow-automation software to reduce administrative load and retain practitioners.
55. 40%+ — Share of dermatology prescribers who are Advanced Practice Providers (APPs).
With APPs writing more than 40% of dermatology prescriptions, integrated e-prescribing modules in dermatology EMRs must be designed for non-physician clinical workflows.
56. 30.5 days — Median wait time in New York City for Medicaid-accepting dermatologists (2024 study).
A 30-day wait even in the nation’s largest city for Medicaid patients reinforces why digital triage and teledermatology access tools have become essential equity solutions.
57. 49% — Practising dermatologists who believe they need more colleagues in their community.
When half of all dermatologists say their local supply is inadequate, it is a powerful indicator of sustained demand for software tools that stretch practitioner capacity.
58. 13 days — Median wait time for private-insurance-only dermatologists in NYC (2024 study).
The 17-day gap between Medicaid and private-insurance wait times highlights a payer disparity that teledermatology platforms are actively working to address.
59. 56% — NYC dermatologists allowing online appointment booking as of 2024.
Only 56% of NYC dermatologists offered online scheduling in 2024, revealing a significant untapped opportunity for patient-engagement software adoption.
🔬 SKIN DISEASE BURDEN
60. 900 million — People globally affected by skin diseases.
With 900 million patients worldwide, skin disease is one of the most prevalent disease categories globally, creating a massive demand base for dermatology software solutions.
61. 30–70% — Estimated share of the global population with some form of skin disorder at any given time.
The extraordinary breadth of skin disease prevalence — affecting up to 70% of people — positions dermatology as a mass-market healthcare category requiring scalable digital solutions.
62. 125 million — People globally affected by psoriasis.
Psoriasis alone affects 125 million people worldwide, creating a high-volume, chronic-care use case that strongly favours integrated monitoring and patient-engagement software.
63. 9.4% — Global population prevalence of acne (NIH).
Acne’s near-universal prevalence — affecting nearly one in ten people globally — means any dermatology software platform targeting acne management has an enormous addressable market.
64. 28.3% — Global acne prevalence per Pierre Fabre’s comprehensive study.
Using a broader diagnostic definition, more than a quarter of the global population experiences acne, underscoring the scale of demand for digital management and teledermatology tools.
65. 50 million — Americans suffering from acne (American Academy of Dermatology).
Fifty million US acne patients represent a massive and under-digitised care population that dermatology apps and teledermatology platforms are actively targeting.
66. 2–3 million — New non-melanoma skin cancer (NMSC) cases globally each year (WHO).
Millions of new NMSC cases annually make early-detection AI software a public health imperative, not merely a commercial product.
67. 1.94% — Estimated annual percentage change (EAPC) in age-standardised skin cancer incidence globally, 1990–2021.
A nearly 2% annual increase in skin cancer incidence over three decades creates a compounding demand driver for AI-assisted detection and dermatology software platforms.
68. 4th — Ranking of skin diseases as a cause of non-fatal disease burden globally (NIH/GMInsights).
Skin diseases being the fourth-leading cause of non-fatal burden globally is a rarely cited statistic that powerfully justifies the healthcare system’s investment in dermatology digital tools.
69. 310% — Increase in squamous cell carcinoma incidence from 1990 to 2017.
A tripling of SCC over 27 years is a stark reminder that skin cancer’s epidemiological trajectory demands immediate, technology-assisted interventions in screening and care delivery.
70. 161% — Increase in melanoma incidence from 1990 to 2017.
Melanoma incidence nearly tripling in under three decades underlines the urgency of AI-assisted early detection tools and the dermatology software platforms that support them.
🌐 BROADER DERMATOLOGY MARKET
71. USD $21.8 billion — Global dermatology market size in 2024 (all segments).
The $22 billion overall dermatology market dwarfs the software sub-segment, illustrating the enormous downstream spending that digital tools help manage and optimise.
72. USD $48.7 billion — Global dermatology market forecast by 2034.
Projected to grow to $49 billion by 2034, the broader dermatology sector will generate a proportionally larger need for specialised software infrastructure.
73. 8.4% CAGR — Overall dermatology market growth rate 2024–2034.
A near 8.5% CAGR for the overall market confirms that dermatology is a high-growth healthcare segment attracting significant pharma, device, and digital investment.
74. 29% — Skin cancer diagnosis and treatment’s share of dermatology market revenue in 2024.
Skin cancer representing nearly a third of all dermatology revenues makes it the single largest application category, driving demand for AI diagnostics and integrated oncology-dermatology software.
75. USD $52.02 billion — Global dermatology treatment and care market value in 2023.
The $52 billion treatment and care market underpins strong software spending as practices invest in digital tools to manage the administrative and clinical complexity of high-volume patient loads.
76. 9.86% CAGR — Dermatology treatment and care market growth 2020–2023.
Consistent near-double-digit growth over several years demonstrates the sector’s structural resilience and its immunity to typical healthcare budget cycles.
77. 12.8% CAGR — Overall dermatology market growth rate 2024–2029 (Technavio).
Technavio’s 12.8% forecast — the highest across major research houses — reflects the compounding impact of teledermatology, biologics, and AI-driven demand creation.
78. USD $19.17 billion — Absolute market expansion in dermatology between 2024 and 2029.
Adding $19 billion in market value within five years is a once-in-a-generation growth event that will reshape practice management, billing, and software vendor competitive dynamics.
79. 41% — North America’s contribution to global dermatology market growth 2024–2029.
North America driving 41% of absolute growth while also leading adoption makes it both the primary revenue market and the key product-innovation benchmark for dermatology software.
80. USD $1.61 billion — Global dermatology market (devices + therapeutics) in 2026.
The devices-and-therapeutics segment alone reaching $1.6 billion in 2026 means that software platforms integrating device management workflows have a large and growing addressable user base.
81. 6.94% CAGR — Global dermatology market (devices + therapeutics) growth 2026–2035.
Steady 7% growth in the devices and therapeutics segment will sustain long-term software investment as practices continuously upgrade clinical tools alongside digital infrastructure.
82. 22% — Asia Pacific’s share of dermatology market revenue in 2024.
Asia Pacific’s one-in-five revenue share, combined with the fastest-growing teledermatology adoption, makes the region the most strategically important emerging market for software vendors.
83. USD $23.9 billion — Global dermatological drugs market in 2024 (Grand View Research).
The $24 billion drug market generates prescription management and formulary integration requirements that drive specialised e-prescribing and drug-interaction software demand.
84. USD $42.3 billion — Dermatological drugs market forecast by 2030.
Nearly doubling the drugs market by 2030 means that e-prescribing modules within dermatology EMRs will need to process substantially higher volumes of complex biologic prescriptions.
85. 36.3% — Psoriasis segment share of dermatology drugs market in 2024.
Psoriasis drugs’ dominance at 36% reflects the chronic, high-cost nature of the condition — and the need for specialised longitudinal tracking software to manage biologic therapy adherence.
86. USD $48.29 billion — Global dermatology drug market in 2024 (MRFR methodology).
Across methodologies the dermatology drug market sits firmly above $23 billion, confirming the enormous financial ecosystem that software platforms must connect to via PBM and pharmacy integrations.
📊 REGIONAL INSIGHTS
87. North America leads — North America is the #1 regional dermatology software market, supported by advanced digital health infrastructure and high EHR adoption.
North America’s first-mover advantage in healthcare digitisation gives vendors who establish early dominance here a template for global expansion.
88. Asia Pacific fastest growing — Asia Pacific is the fastest-growing dermatology software region, driven by rising healthcare investment in China, India, and Japan.
Asia Pacific’s explosive growth trajectory — fuelled by a population exceeding 4 billion and rapidly urbanising healthcare systems — will likely see the region overtake Europe by 2030.
89. USD $0.15 billion — Japan dermatology software market value in 2022.
Japan’s 2022 baseline of $150 million in dermatology software reflects a mature but innovation-driven market where AI and robotic diagnostic tools are gaining regulatory traction.
90. USD $0.25 billion — Japan dermatology software market projection by 2030 (7.7% CAGR).
Japan growing to $250 million by 2030 at a steady 7.7% CAGR reflects consistent incremental adoption rather than disruptive market shifts.
91. 44.94% — North America’s share of the global dermatology drug market in 2024.
Dominating 45% of a $48 billion drug market means North American software vendors serve practitioners handling the most complex, highest-value prescribing workflows in the world.
92. 40.4% — North America’s share of global dermatology drugs market (alternative GMInsights estimate).
Across methodologies, North America holds roughly 40–45% of the dermatology drug market, cementing the region’s status as the primary commercial battleground for dermatology software.
93. 30% — Europe’s share of the global dermatology drug market in 2024.
Europe’s substantial 30% share of the drug market signals strong software infrastructure demand, particularly for regulatory-compliant EHR and pharmacovigilance solutions.
💼 KEY INDUSTRY DRIVERS & ADDITIONAL DATAPOINTS
94. USD $685 million — NIAMS FY2024 funding for dermatology and related research.
Nearly $700 million in US federal research funding flowing into dermatology and skin-disease research annually creates a direct demand for clinical data management and trial software.
95. USD $5.2 billion — An alternative long-range projection for the dermatology software market by 2032 (Verified Market Reports).
The wide range of forecasts ($574M–$5.2B by 2032) reflects differing scope inclusions, but all projections align on strong double-digit long-run growth.
96. USD $110.29 billion — Dermatology treatment and care market forecast by 2030.
Approaching $110 billion in treatment and care spending by 2030 creates an enormous software infrastructure requirement, including billing, prior-authorisation, and outcomes tracking tools.
97. 20% — Share of the US population that had developed some form of skin cancer by age 70 (AAD).
One in five Americans developing skin cancer underscores why AI-powered early-detection software is increasingly viewed as a population health tool rather than a specialist luxury.
98. 35% — Estimated share of healthcare providers leveraging EHR-based clinical decision support tools.
With 35% of providers using clinical decision support, the integration of decision support within dermatology EMRs is the next major differentiation battleground for software vendors.
99. USD $4.9 billion — Private equity invested in EHR companies in 2023.
$4.9 billion in PE investment signals institutional conviction in the EHR market’s growth trajectory, with dermatology-specific platforms attracting a disproportionate share of specialty-focused deals.
100. USD $2.3 billion — Venture capital raised in early-stage EHR startups in 2023.
Early-stage VC flooding into EHR startups in 2023 is laying the foundation for next-generation dermatology software platforms that will come to market between 2025 and 2028.
101. USD $12.87 billion — US EHR market value in 2024.
The broader $13 billion US EHR market, of which dermatology is a fast-growing slice, is growing at a 2.55% CAGR — slower than the dermatology subset, confirming the specialty outperforms the category.
102. 500,000+ — Annual patient visits managed by The Dermatology Specialists (NYC) across 40+ locations using eClinicalWorks.
Managing half a million visits on a single EMR platform demonstrates the scalability of modern dermatology software at enterprise scale.
103. USD $985.7 million — Full-year 2024 revenue for Almirall (dermatology pharma), a 10.2% YoY increase.
A 10% revenue increase for a leading dermatology pharma company reflects the buoyant commercial environment that sustains software investment and new platform development.
Conclusion
The dermatology software market is positioned for sustained growth beyond 2026 as healthcare providers increasingly adopt specialized EMR systems, teledermatology platforms, artificial intelligence, cloud-based solutions, revenue cycle management tools, and digital patient-engagement technologies. With the global dermatology software market estimated at $362.63 million in 2025 and projected to grow at a 10.6% CAGR through 2032, digital transformation is becoming a fundamental part of how dermatology practices operate and deliver care.
Specialized dermatology EMR software represents an important part of this opportunity. The segment was valued at $512.3 million in 2024 and is projected to reach $1.389 billion by 2033 at an 11.6% CAGR. Meanwhile, approximately 80% of U.S. dermatology practices have adopted EHR technology. This suggests that future competition will increasingly center on improving existing systems through interoperability, workflow automation, clinical decision support, AI capabilities, patient engagement, and specialty-specific functionality rather than simply moving practices away from paper records.
Teledermatology stands out as another major growth engine. One estimate places the global teledermatology market at $14.99 billion in 2024 and projects it to reach $41.08 billion by 2030, representing a 17.9% CAGR. Store-and-forward services already accounted for 46.3% of the market in 2024, demonstrating the growing role of asynchronous consultations and medical image sharing in expanding access to dermatological care.
AI is also reshaping the dermatology software landscape. Around 35% of dermatology software platforms feature AI-enhanced image analysis, while research cited in these statistics reported pooled AI sensitivity of 91% for skin-lesion diagnosis. However, pooled specificity of 64% in the same analysis highlights an important limitation: AI’s strongest near-term role may be supporting dermatologists with screening, triage and clinical decision-making rather than functioning as an independent replacement for clinicians.
The demand for better dermatology technology is reinforced by significant healthcare pressures. An estimated 900 million people worldwide are affected by skin diseases, while U.S. patients have faced average dermatology appointment waits of 34.5 days. At the same time, 46% of dermatologists reported burnout, and nearly half believed their communities needed more dermatologists. These pressures create a strong incentive for technologies that allow practices to manage more patients, automate administrative work, improve scheduling, streamline revenue cycles and extend care beyond traditional clinics.
Ultimately, these 103 dermatology software statistics, data and trends for 2026 point toward an industry moving beyond basic practice digitization toward increasingly connected, intelligent and scalable healthcare technology. Cloud software, specialty EMRs, teledermatology, AI-assisted diagnostics, automated billing and digital patient experiences are likely to play increasingly important roles in the next phase of the market.
For dermatology practices, healthcare technology companies, software vendors and investors, the opportunity is therefore broader than simply selling another medical software platform. The technologies that can demonstrably reduce administrative workloads, improve access to dermatologists, support clinical decisions and strengthen practice economics are likely to be best positioned as dermatology software continues its expansion through the remainder of the decade.
If you find this article useful, why not share it with your hiring manager and C-level suite friends and also leave a nice comment below?
We, at the 9cv9 Research Team, strive to bring the latest and most meaningful data, guides, and statistics to your doorstep.
To get access to top-quality guides, click over to 9cv9 Blog.
To hire top talents using our modern AI-powered recruitment agency, find out more at 9cv9 Modern AI-Powered Recruitment Agency.
People Also Ask
What is dermatology software?
Dermatology software is specialized healthcare technology that helps dermatology practices manage electronic health records, scheduling, billing, clinical workflows, medical images, prescriptions, teledermatology and patient engagement.
How big is the dermatology software market in 2026?
The research lists a $362.63 million market valuation for 2025. It does not provide a directly stated overall dermatology software market value for 2026, but projects a 10.6% CAGR from 2025 to 2032.
How fast is the dermatology software market growing?
The global dermatology software market is projected to grow at a 10.6% CAGR from 2025 to 2032, supported by AI integration, EHR adoption, teledermatology and rising demand for digital healthcare.
What will the dermatology software market be worth by 2032?
The research projects the global dermatology software market to reach approximately $734.10 million by 2032 under one market forecast. Other estimates vary because researchers use different market definitions.
What are the biggest dermatology software trends in 2026?
Major trends include AI-assisted image analysis, cloud-based platforms, specialty EMRs, teledermatology, automated revenue cycle management, clinical decision support and improved digital patient experiences.
How big is the dermatology EMR software market?
The global dermatology EMR software market was valued at $512.3 million in 2024 and is projected to reach $1.389 billion by 2033, according to the research.
How fast is the dermatology EMR software market growing?
Dermatology EMR software is projected to grow at an 11.6% CAGR between 2025 and 2033, making specialty electronic medical records an important growth segment within dermatology technology.
What percentage of dermatology practices use EHR systems?
Approximately 80% of U.S. dermatology practices use EHR technology, indicating that electronic health records have already achieved widespread adoption within American dermatology.
How long does dermatology EMR implementation take?
A new dermatology EMR system typically takes around six to eight weeks to implement, according to the research, although actual deployment times can depend on practice size and requirements.
What percentage of dermatology software is cloud-based?
More than 60% of dermatology software was estimated to be cloud-based in 2025, reflecting growing demand for easier multi-location access, automatic updates and reduced on-premise IT requirements.
How is AI being used in dermatology software?
AI is increasingly used for skin-image analysis, lesion classification, screening, triage and clinical decision support. Around 35% of dermatology software platforms feature AI-enhanced image analysis tools.
How accurate is AI for skin lesion diagnosis?
A 2025 meta-analysis cited in the research reported an AUROC of 0.88 across more than 70,000 test images, with pooled sensitivity of 91% and pooled specificity of 64%.
Can AI replace dermatologists?
The statistics support AI as an augmentation, screening and triage technology rather than a standalone replacement. The cited meta-analysis found 91% pooled sensitivity but only 64% pooled specificity.
What is teledermatology?
Teledermatology delivers dermatological care remotely using digital communication and medical images. It can include live video consultations and asynchronous store-and-forward services where dermatologists review submitted images.
How big is the teledermatology market?
One estimate valued the global teledermatology market at $14.99 billion in 2024. Another methodology estimated it at $9.03 billion, demonstrating substantial differences in market definitions.
How fast is teledermatology growing?
One forecast projects the global teledermatology market to grow at a 17.9% CAGR from 2025 to 2030, while other estimates cited in the research range from 15.1% to 20.2%.
How large could the teledermatology market become by 2030?
The research cites a forecast of $41.08 billion for the global teledermatology market by 2030, compared with a reported $14.99 billion valuation in 2024 under the same methodology.
What is store-and-forward teledermatology?
Store-and-forward teledermatology allows patient information and skin images to be captured and sent to a dermatologist for later review. This asynchronous model accounted for 46.3% of the global market in 2024.
Which region leads the dermatology software market?
North America leads the global dermatology software market, supported by high EHR adoption, advanced healthcare infrastructure and digital health investment. Asia Pacific is identified as the fastest-growing region.
Why is Asia Pacific important for dermatology software growth?
Asia Pacific is identified as the fastest-growing dermatology software region, with rising healthcare investment and digital adoption in major markets including China, India and Japan.
How can dermatology software improve practice revenue?
Specialized dermatology RCM software was associated with a 10% increase in revenue and cash flow in the research. RCM optimization can also reduce claim delays and payer rejections.
Can dermatology software reduce insurance claim rejections?
The research reports a 33% reduction in payer rejections following RCM optimization, demonstrating how billing and revenue cycle technology can reduce administrative inefficiencies.
Can dermatology software improve collection rates?
A 120-plus-provider New York dermatology practice achieved a 99% net collection rate after implementing eClinicalWorks RCM, according to the case study cited in the research.
Why is demand for dermatology software increasing?
Demand is being driven by rising skin disease prevalence, long appointment waits, clinician shortages, burnout, EHR adoption, telehealth expansion and the growing use of AI and cloud technology.
How many people worldwide have skin diseases?
An estimated 900 million people globally are affected by skin diseases. The research also cites estimates suggesting that 30% to 70% of the global population has a skin disorder at any given time.
How long do patients wait for a dermatologist appointment?
The research reports an average U.S. dermatology appointment wait of 34.5 days in 2022, representing a 7% increase compared with 2017.
How common is dermatologist burnout?
Approximately 46% of dermatologists reported burnout in the Medscape 2024 Physician Burnout & Depression Report cited by the research. Workflow automation may help reduce administrative workloads.
How can teledermatology improve access to dermatologists?
Teledermatology can extend specialist access beyond traditional clinics through remote consultations and asynchronous image review, helping healthcare systems respond to long appointment waits and dermatologist shortages.
What features are becoming important in dermatology software?
Important capabilities include specialty EHRs, cloud access, AI image analysis, teledermatology, online scheduling, e-prescribing, billing and RCM, clinical decision support, medical imaging and patient engagement.
What is the future of dermatology software after 2026?
The statistics point toward continued adoption of cloud platforms, AI-assisted workflows, teledermatology and specialized EMRs. Market forecasts through the 2030s indicate sustained growth in dermatology technology and digital care.
Sources
Reanin Research Verified Market Reports Fundamental Business Insights Zion Market Research Growth Market Reports Grand View Research Market.us Market Research Future Mordor Intelligence Straits Research Expert Market Research Precedence Research EMRFinder MedicalRecords Tjiu JW & Lu CF Karimzadhagh S et al. Behara K, Bhero E, Agee JT Intuition Labs Healio Healthgrades Basch CH et al. eClinicalWorks Unlimited Systems Emergen Research Technavio Towards Healthcare ResearchAndMarkets BusinessWire GMInsights SingleCare Nature Scientific Reports PMC Aptarro PatientNow Derm Care Billing Consultants
